12 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

POWDERED VINYL PATIENT EXAMINATION GLOVES, (LIGHT YELLOW)

FDA 510(k)
FDA Class 1 ·General Hospital

AVALIGN

FDA Adverse Event
Malfunction ·AVALIGN GERMAN SPECIALTY INSTRUMENTS·Product code HAE·June 17, 2019

HDR TANDEM/RING APPLICATOR WITH RECTAL RETRACTOR

FDA 510(k)
FDA Class 2 ·Radiology

UKNEE TOTAL KNEE SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

RAINBOW R1 25L SENSOR

FDA Adverse Event
Malfunction ·MASIMO CORPORATION·Product code DQA·June 19, 2015

HOMECHOICE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - LARGO·Product code FKX·April 29, 2013

ECHELON 60

FDA Adverse Event
Malfunction ·ETHICON ENDO-SURGERY, LLC.·Product code GDW·May 9, 2011

8F ANGIO-SEAL VASCULAR CLOSURE DEVICE STS PLUS

FDA Adverse Event
Injury ·ST. JUDE MEDICAL·Product code MGB·July 23, 2008

Femoral Nail, LEFT T2 GTN ¿12x360 mm, Product Number 18501236S

FDA Enforcement
Class II ·Terminated·Stryker GmbH·July 18, 2018

Femoral Nail, A/R T2 Femur ¿12x360 mm, Product Number 18251236S

FDA Enforcement
Class II ·Terminated·Stryker GmbH·July 18, 2018

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024